Search Within

Guido Dalbagni

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (34)
  2. Journal Article (23)
  3. Editorial (1)
Groups
  1. Human Oncology and Pathogenesis Program (58)
  2. Surgery (58)
  3. Urology (58)
  4. Department of Pathology and Laboratory Medicine (56)
  5. Department of Medicine (55)
  6. Genitourinary Oncology Service (55)

More Groups

People
  1. Hikmat Al-Ahmadie (55)
  2. Bernard Bochner (51)
  3. David Solit (51)
  4. Gopakumar Iyer (50)
  5. Dean Bajorin (46)
  6. Jonathan Rosenberg (39)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (3)
  4. 2022 (4)
  5. 2021 (4)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (13)
  2. Modern Pathology (10)
  3. Laboratory Investigation (9)
  4. Clinical Cancer Research (4)
  5. European Urology (4)
  6. Urologic Oncology: Seminars and Original Investigations (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (15)
  2. Nature Publishing Group (11)
  3. Nature Research (10)
  4. Elsevier Inc. (6)
  5. American Association for Cancer Research (5)
  6. Elsevier Science, Inc. (5)

More Publishers

Results (58)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final results of a multicenter prospective phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy in patients with high-grade upper tract urothelial carcinoma
    Meeting Abstract

    Yip, W.; Coleman, J.; Wong, N. C.; Sjoberg, D. D.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Pietzak, E. J.; Hakimi, A. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Human epidermal growth factor receptor 2 (HER2) and fibroblast growth factor receptor 3 (FGFR3) mutations to reveal biological pathways in urothelial carcinoma
    Meeting Abstract

    Chu, C. E.; De Jesus Escano, M.; Yip, W.; Jiang, S.; Iyer, G.; Al-Ahmadie, H. A.; Goh, A. C.; Dalbagni, G.; Bochner, B. H.; Solit, D. B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Large cell neuroendocrine carcinoma of the urothelial tract (LNEC): The MSKCC experience
    Meeting Abstract

    Guercio, B. J.; Gandhi, J.; Teo, M. Y.; Lattanzi, M.; Funt, S. A.; Aggen, D. H.; Chen, Y. B.; Fine, S.; Pietzak, E. J.; Bochner, B. H.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Identification of a novel inflamed tumor microenvironment signature as a predictive biomarker of bacillus Calmette-Guérin immunotherapy in non-muscle-invasive bladder cancer
    Journal Article

    Damrauer, J. S.; Roell, K. R.; Smith, M. A.; Sun, X.; Kirk, E. L.; Hoadley, K. A.; Benefield, H. C.; Iyer, G.; Solit, D. B.; Milowsky, M. I.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • A phase I trial of chemoimmunotherapy combining bacillus Calmette-Guerin (BCG) and intravesical gemcitabine for patients with BCG-relapsing high-grade nonmuscle-invasive bladder cancer
    Meeting Abstract

    De Jesus Escano, M. R.; Sjoberg, D. D.; McCarter, M.; McGill, M.; Goh, A.; Donahue, T. F.; Donat, M. S.; Cha, E. K.; Herr, H. W.; Meraney, A. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma
    Journal Article

    Teo, M. Y.; Al-Ahmadie, H.; Seier, K.; Tully, C.; Regazzi, A. M.; Pietzak, E.; Solit, D. B.; Tickoo, S.; Reuter, V.; Cha, E. K.; more...
    British Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Fibroblast growth factor receptor 3 alteration status is associated with differential sensitivity to platinum-based chemotherapy in locally advanced and metastatic urothelial carcinoma
    Journal Article

    Teo, M. Y.; Mota, J. M.; Whiting, K. A.; Li, H. A.; Funt, S. A.; Lee, C. H.; Solit, D. B.; Al-Ahmadie, H.; Milowsky, M. I.; Balar, A. V.; more...
    European Urology (2020)

    Fulltext@MSK | Save
  • Next-generation sequencing of Bacille Calmette-Guerin (BCG)-unresponsive tumors identifies actionable alterations for potential targeted therapy in non-muscle invasive bladder cancer
    Meeting Abstract

    Walasek, A.; Almassi, N.; McPherson, V.; Dason, S.; Benfante, N.; Klein, T.; Berger, M. F.; Schultz, N.; Dalbagni, G.; Bajorin, D. F.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Characterization of tumor mutational landscape in smokers and nonsmokers with urothelial carcinoma
    Meeting Abstract

    Walasek, A.; Almassi, N.; Teo, M. Y.; Funt, S.; Schultz, N.; Dalbagni, G.; Hu, W.; Al-Ahmadie, H.; Bajorin, D. F.; Rosenberg, J. E.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Genomic determinants of nested variant urothelial carcinoma
    Meeting Abstract

    Clinton, T. N.; Whiting, K.; Silva, V.; Li, Q.; Almassi, N.; Pietzak, E.; Bagrodia, A.; Cha, E. K.; Dalbagni, G.; Iyer, G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save